§ Dr. FoxTo ask the Secretary of State for Health what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. [38678]
§ Yvette Cooper[holding answer 28 February 2002]: The contract was awarded to Powderject under European Union public procurement regulations.
Powderject was the only manufacturer with a United Kingdom licence to supply BCG vaccine at that time.